Cosmetics

A Cosmetics Adverse Reaction Monitoring System has been launched in China to strengthen & improve the efficiency of monitoring nationwide

The medtech, cosmetics and pharmaceutical webinars will cover important China regulatory updates presented by our Cisema regulatory experts.

China cosmetics registration certificates for special cosmetics and new cosmetic ingredients will be issued electronically from Oct. 1, 2022

NMPA has issued draft measures for the supervision and administration of China cosmetics online operations

Innovative provisions for cosmetics in Pudong, Shanghai aims to enable customizable product packaging, optimize the route-to-market, etc.

Cosmetics GMP Good Manufacturing Practices came into force in China on July 1, 2022. Contact Cisema to see if it affects your production.

China cosmetics sampling inspections are to be strengthened through newly proposed measures for products using a new ingredient.

NMPA solicits comments on the revised draft of China's medical device classification for sodium hyaluronate products until June 16, 2022.

China cosmetics label requirements have been clarified by the NIFDC for antioxidants, preservatives, stabilizers added as cosmetic ingredients

China cosmetics quality and safety managers must be appointed to meet the CSAR requirements for filing or registration of cosmetics

CSAR China cosmetics infringements are increasing as witnessed recently with the suspension of production of lavender essential oil

Webinar "China Cosmetics Ingredient Code Submission" will be held on June 15, 2022, for cosmetics manufacturers and ingredients suppliers.